Vision Performance Centre, Military Medicine Institute, Singapore Armed Forces, Singapore, Singapore.
National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.
Clin Exp Ophthalmol. 2020 Jul;48(5):558-568. doi: 10.1111/ceo.13759. Epub 2020 Apr 22.
This study reports outcomes of myopic photorefractive keratectomy (PRK) in a mainly ethnic Chinese population in Singapore.
To assess the incidence and associations of corneal haze and endothelial cell count (ECC) loss up to 12 months after PRK.
This was a retrospective case series conducted in a tertiary eye centre.
A total of 158 patients (309 eyes) with a mean age of 22.1 ± 3.4 years were included. The majority was Chinese (97.4%) and male (97.4%). Mean preoperative spherical equivalent was -3.33 ± 1.15 D.
Eyes were categorized based on postoperative haze severity. A multivariate analysis adjusting for age and use of intraoperative mitomycin-C (MMC), preoperative sphere and cylinder was performed.
Refractive outcomes and corneal haze 3 and 12 months after PRK were assessed. ECC measurements were obtained before PRK and at variable periods postoperatively.
At 12 months, overall efficacy index was 0.98, and safety index was 1.09. Eight (2.5%) eyes underwent enhancement surgery. An analysis was performed on 295 eyes that did not undergo enhancement and had complete clinical data, which demonstrated a decrease in the incidence of haze from 38.2% at 3 months to 9.3% at 12 months. Higher myopia was associated with increased haze severity at 3 months (OR, 1.36; P = .005). Higher astigmatism was associated with increased haze severity at 3 (OR, 1.65; P = .018) and 12 months (OR, 2.32; P = .015). Intraoperative MMC was not associated with haze severity or ECC loss.
Myopia and astigmatism were associated with increased corneal haze severity. Intraoperative MMC did not accelerate ECC loss. Overall, PRK is effective, predictable and safe in Asian eyes.
本研究报告了在新加坡主要是华人群体中进行的近视光折射性角膜切削术(PRK)的结果。
评估 PRK 术后 12 个月内角膜混浊和内皮细胞计数(ECC)丧失的发生率和相关性。
这是一项在三级眼科中心进行的回顾性病例系列研究。
共纳入 158 名(309 只眼)平均年龄为 22.1±3.4 岁的患者。大多数为中国人(97.4%)和男性(97.4%)。平均术前球镜等效值为-3.33±1.15D。
根据术后混浊严重程度对眼睛进行分类。进行了一项多变量分析,调整了年龄、术中丝裂霉素 C(MMC)的使用、术前球镜和柱镜。
评估 PRK 后 3 个月和 12 个月的屈光结果和角膜混浊。在 PRK 之前和术后不同时间测量 ECC。
12 个月时,总体疗效指数为 0.98,安全指数为 1.09。8 只(2.5%)眼行增强手术。对未行增强且具有完整临床资料的 295 只眼进行了分析,结果显示 3 个月时混浊发生率从 38.2%下降至 12 个月时的 9.3%。高度近视与 3 个月时混浊程度加重相关(OR,1.36;P=0.005)。较高的散光与 3 个月(OR,1.65;P=0.018)和 12 个月(OR,2.32;P=0.015)时混浊程度加重相关。术中使用丝裂霉素 C与混浊严重程度或 ECC 丧失无关。
近视和散光与角膜混浊程度加重相关。术中使用丝裂霉素 C不会加速 ECC 丧失。总体而言,PRK 在亚洲人群中是有效、可预测且安全的。